Jove
Visualize
お問い合わせ

関連する概念動画

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

326
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
326
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

284
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
284
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
366
Stress and Mental Health01:30

Stress and Mental Health

211
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
211
Altered States of Awareness01:06

Altered States of Awareness

462
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
462
Stimulants01:29

Stimulants

312
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
312

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

How Partisan Policies Can Shape Health Behaviors: Executive Order Proof-of-Vaccine Mandate Bans Increased COVID-19 Vaccinations.

Vaccines·2026
Same author

Treating Obesity With Pharmacotherapy: Making Sense of the Evolving Science When Data Are Vast but Direct Comparative Evidence Is Sparse.

Annals of internal medicine·2026
Same author

Study Design Indexing in Transition: A Focused Comparison of manual NLM Indexing vs. Transformer-based Automated Models.

medRxiv : the preprint server for health sciences·2026
Same author

US Air Quality Index and respiratory health outcomes: background, knowledge gaps, and research prioritization: an Official American Thoracic Society Research Statement.

American journal of respiratory and critical care medicine·2026
Same author

Topical immunosuppressants for blepharitis in adults.

The Cochrane database of systematic reviews·2026
Same author

Food Security Outlook for Eastern Africa by 2050: Climate Change Impacts and Population-Driven Demand Gaps.

Current environmental health reports·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Sep 10, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

193

高濃度デルタ-9-テトラヒドロカンナビノールの大麻製品と精神保健の成果:体系的なレビュー

Thanitsara Rittiphairoj1, Louis Leslie2, Jean-Pierre Oberste2

  • 1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (T.R.).

Annals of internal medicine
|August 25, 2025
PubMed
まとめ

高濃度のデルタ9テトラヒドロカンナビノール (THC) 製品は,特に精神病や大麻使用障害などの精神的健康への悪影響と関連しています. 不安やうつ病の治療に 役立つ可能性があるという証拠もありますが 矛盾しています

さらに関連する動画

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.8K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

329

関連する実験動画

Last Updated: Sep 10, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

193
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.8K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

329

科学分野:

  • 大麻の研究
  • メンタルヘルス科学
  • 薬理学について

背景:

  • 大麻市場では,高濃度のデルタ9テトラヒドロカンナビノール (THC) 製品が増加しています.
  • これらの強力な薬の メンタルヘルスへの影響を理解することは 極めて重要です

研究 の 目的:

  • 高濃度THCカンナビス製品と精神疾患との関連に関する科学文献を体系的に検討する.
  • 精神病,不安,うつ病,大麻使用障害 (CUD) に関する証拠をまとめること.

主な方法:

  • 複数のデータベースを介して包括的な文献検索が行われました.
  • 高濃度THCを1食分の5mgまたは10%以上または製品タイプ (例えば"シャッター"",ダブ") で定義した試験は含まれていた.
  • 評価されたアウトカムには,不安,うつ,精神病/統合失調症,CUDが含まれ,結果は関連性および研究タイプによって分類されました.

主要な成果:

  • 22万1000人以上の参加者を含む99件の研究が分析され,ほとんどの研究でバイアスのリスクは中等から高かった.
  • 非治療的な研究では,高濃度のTHCと精神病/統合失調症 (70%) とCUD (75%) の間の不良な関連が一貫して示されました.
  • 不安やうつ病に対する高THC製品の治療効果に関する証拠は低品質で不一致で,いくつかの研究では不利な関連が報告されました.

結論:

  • 高濃度のTHC製品は,特に精神病とCUDなどの不良な精神的健康結果と関連しています.
  • 不安とうつ病に対する潜在的な治療効果は,低品質で矛盾する証拠のためにさらなる調査を必要とします.
  • 限界には研究バイアスと現代の大麻製品を評価する必要性があります.